<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01433952</url>
  </required_header>
  <id_info>
    <org_study_id>132653</org_study_id>
    <nct_id>NCT01433952</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Oral Thiamine</brief_title>
  <official_title>Pharmacokinetics of High Dose Oral Thiamine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baystate Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baystate Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Elevated levels of thiamine may increase cellular energy metabolism by increasing the&#xD;
      activity of pyruvate dehydrogenase complex. This has been hypothesized to have a beneficial&#xD;
      affect in patients with several diseases including sepsis, heart failure, and diabetes. There&#xD;
      is limited data on the pharmacokinetics of supraphysiologic doses of oral thiamine.&#xD;
&#xD;
      The aims of this study are to:&#xD;
&#xD;
        -  Calculate the plasma and whole blood pharmacokinetics of supraphysiologic doses of oral&#xD;
           thiamine in healthy volunteers;&#xD;
&#xD;
        -  Compare the different thiamine doses on the pharmacokinetic variables using repeated&#xD;
           measures ANOVA.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area Under the Curve (AUC) for whole blood</measure>
    <time_frame>predose, 0, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10 hours post-dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Area Under the Curve (AUC) for plasma</measure>
    <time_frame>predose, 0, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10 hours post-dose</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Pharmacokinetics in Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>0 mg Thiamine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>100 mg Thiamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>500 mg Thiamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>1500 mg Thiamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Thiamine</intervention_name>
    <description>Vitamin B1</description>
    <arm_group_label>100 mg Thiamine</arm_group_label>
    <arm_group_label>1500 mg Thiamine</arm_group_label>
    <arm_group_label>500 mg Thiamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>0 mg Thiamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 55&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non dietary thiamine supplement within two weeks of the start of the study or during&#xD;
             the study&#xD;
&#xD;
          -  History of thiamine deficiency&#xD;
&#xD;
          -  Anemia (Hgb&lt;10)&#xD;
&#xD;
          -  History of gastrointestinal absorption disorders&#xD;
&#xD;
          -  Taking prescription or over-the-counter medication&#xD;
&#xD;
          -  Pregnant or breast feeding a child&#xD;
&#xD;
          -  Alcohol and or drug abuse&#xD;
&#xD;
          -  Smoker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Smithline, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baystate Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <study_first_submitted>September 7, 2011</study_first_submitted>
  <study_first_submitted_qc>September 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2011</study_first_posted>
  <last_update_submitted>September 13, 2011</last_update_submitted>
  <last_update_submitted_qc>September 13, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thiamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

